Sing Pharma

SingPharma is a Singapore-based specialty pharmaceutical company dedicated to the development and commercialization of value-added medicines (VAMs) and super generics. The company focuses on enhancing existing therapeutic agents through innovative formulation and drug delivery technologies to improve patient outcomes and safety. Its primary therapeutic focus lies in orthopedics and pain management, with its lead product, SingJoint, being a widely used viscosupplement for knee osteoarthritis. SingPharma aims to address unmet clinical needs by providing cost-effective and improved versions of established drugs for the global market. The company leverages the 505(b)(2) regulatory pathway to accelerate the approval of its reformulated products. By optimizing drug delivery, SingPharma seeks to reduce side effects and enhance the therapeutic index of well-known molecules.